Table 3 Disease specific hospital admissions and emergency-department (ED) visits in participants with or without ILA
From: Increased respiratory morbidity in individuals with interstitial lung abnormalities
Disease group | HR | 95% CI | Adjusted p-value |
|---|---|---|---|
Respiratory disease | 2.1 | 1.4–3.1 | 0.001 |
 COPD | 2.5 | 0.9–6.8 | 0.10 |
 Pneumonia | 2.1 | 1.5–3.0 | 0.001 |
 Asthma | 0.8 | 0.1–7.7 | 0.90 |
 Pleural empyema or lung abscess | 0.3 | 0.0–32.6 | 0.90 |
 Interstitial lung disease | 1.8 | 0.3–12.5 | 0.82 |
Malignant neoplasm | 1.6 | 1.2–2.1 | 0.001 |
 Lung cancer | 2.8 | 1.7–4.5 | 0.001 |
 Non-pulmonary cancer | 1.3 | 0.9–1.9 | 0.15 |
Cardiovascular disease | 1.4 | 1.0–1.8 | 0.10 |
 Heart failure | 2.2 | 1.3–4.1 | 0.09 |
 Pulmonary embolism | 4.9 | 1.6–14.7 | 0.01 |
 Atrial fibrillation/atrial flutter | 1.3 | 0.5–3.3 | 0.82 |
 Ischemic heart disease | 1.1 | 0.8–1.6 | 0.90 |
 Cerebral infarction | 1.5 | 0.8–2.7 | 0.43 |
 Peripheral vascular disease | 5.0 | 2.5–9.9 | 0.001 |
Gastrointestinal disease | 1.1 | 0.8–1.6 | 0.87 |
 GORD, gastritis or ulcer disease | 0.9 | 0.3–2.2 | 0.90 |
 Functional intestinal disorders | 1.1 | 0.4–3.0 | 0.90 |
Diseases of the musculoskeletal system and connective tissue | 1.1 | 0.8–1.4 | 0.90 |
 Inflammatory polyarthropathies | 1.5 | 0.9–2.4 | 0.95 |